Skip to main content
. 2022 May 11;10(5):e004839. doi: 10.1136/jitc-2022-004839

Figure 3.

Figure 3

(A) Progression-free survival of BCC patients treated with PD-1 inhibition. (B) Overall survival of BCC patients treated with PD-1 inhibition. BCC, basal cell carcinoma.